Vaccine effectiveness
against symptomatic disease
100 unvaccinated people who would have developed symptoms after a Covid infection
35%
After dose one
79%
After dose two
Protected against
developing symptoms
Not protected
Vaccine effectiveness
against hospitalisation
100 unvaccinated people who would have been hospitalised after a Covid infection
80%
After dose one
96%
After dose two
Protected against
hospitalisation
Not protected
Vaccine effectiveness
against symptomatic disease
Vaccine effectiveness
against hospitalisation
100 unvaccinated people who would have developed symptoms after a Covid infection
100 unvaccinated people who would have been hospitalised after a Covid infection
35%
After dose one
79%
After dose two
80%
After dose one
96%
After dose two
Protected against
developing symptoms
Protected against
hospitalisation
Not protected
Not protected